Fatty acid composition of erythrocyte phospholipids is related to insulin levels, secretion and resistance in obese type 2 diabetics on Metformin

Clinica Chimica Acta

Volumn 346, Issue 2, 2004, Pages 145-152

  Enriquez, Yanik Rodríguez ^a   Giri, Mimi ^b   Rottiers, Raoul ^b   Christophe, Armand ^b  

^a Instituto de Nutricion e Higiene de los Alimentos   (Cuba)

^b GHENT UNIVERSITY HOSPITAL   (Belgium)

Author keywords

BMI; body mass index; Fasting serum insulin; Fatty acid composition; HOMA; HOMA R; homeostasis model assessment; Insulin resistance; Insulin secretion; RBC; Red blood cell phospholipids; red blood cells; Type 2 diabetes

Indexed keywords

FATTY ACID; LINOLEIC ACID; METFORMIN; MONOUNSATURATED FATTY ACID; OLEIC ACID; OMEGA 3 FATTY ACID; OMEGA 6 FATTY ACID; PALMITIC ACID; PHOSPHOLIPID; POLYUNSATURATED FATTY ACID; SATURATED FATTY ACID;

ADULT; AGED; ARTICLE; BLOOD ANALYSIS; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DIET RESTRICTION; DISEASE ASSOCIATION; ERYTHROCYTE; FEMALE; HUMAN; INSULIN BLOOD LEVEL; INSULIN RELEASE; INSULIN RESISTANCE; INSULIN SENSITIVITY; LIPID COMPOSITION; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; PRIORITY JOURNAL; TEST MEAL; TREATMENT OUTCOME;

ADULT; AGE FACTORS; AGED; BIOLOGICAL MARKERS; DIABETES MELLITUS, TYPE 2; DIETARY FATS; ERYTHROCYTES; FATTY ACIDS; HUMANS; INSULIN; INSULIN RESISTANCE; MALE; METFORMIN; MIDDLE AGED; OBESITY; PHOSPHOLIPIDS;

EID: 3142576699     PISSN: 00098981     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cccn.2004.02.029     Document Type: Article

References (41)

1. Poitout V., Robertson R.P. Minireview: secondary β-cell failure in type 2 diabetes - a convergence of glucotoxicity and lipotoxicity. Endocrinology. 143:2002;339-342
2. Groop L. Pathogenesis of type 2 diabetes: the relative contribution of insulin resistance and impaired insulin secretion. Int. J. Clin. Pract. Suppl. 113:2000;3-13
3. Wilding J.P.H. Obesity and nutritional factors in the pathogenesis of type 2 diabetes mellitus. Pickup J.C., Williams G. Textbook of Diabetes. 2003;22.1-22.19 Blackwell, UK
4. Di Marino L., Maffettone A., Cipriano P., Sacco M., Di Palma R., Amato B. Is the erythrocyte membrane fatty acid composition a valid index of skeletal muscle membrane fatty acid composition? Metabolism. 49:2000;1164-1166
5. Katan M.B., Deslypere J.P., van Birgelen A.P., Penders M., Zegwaard M. Kinetics of the incorporation of dietary fatty acids into serum cholesteryl esters, erythrocyte membranes and adipose tissue: an 18-month controlled study. J. Lipid Res. 38:1997;2012-2022
6. Tinahones F.J., Pareja A., Soriguer F.J., Gomez-Zumaquero J.M., Cardona F., Rojo-Martinez G. Dietary fatty acids modify insulin secretion of rat pancreatic islets cells in vitro. J. Endocrinol. Invest. 25:2002;436-441
7. Baur L.A., O'Connor J., Pan D.A., Wu B.J., O'Connor M.J., Storlien L.H. Relationships between the fatty acid composition of muscle and erythrocyte membrane phospholipid in young children and the effect of type of infant feeding. Lipids. 35:2000;77-82
8. Dang A.Q., Faas F.H., Jethmalani S.M., Carter W.J. Decreased incorporation of long-chain fatty acids into erythrocyte phospholipids of STZ-D rats. Diabetes. 40:1991;1645-1651
9. Stubbs C.D., Smith A.D. The modification of mammalian membrane polyunsaturated fatty acid composition in relation to membrane fluidity and function. Biochim. Biophys. Acta. 779:1984;89-137
10. Folsom A.R., Ma J., McGovern P.G., Eckfeldt H. Relation between plasma phospholipid saturated fatty acids and hyperinsulinemia. Metabolism. 45:1996;223-228
11. Clifton P.M., Nestel P.J. Relationship between plasma insulin and erythrocyte fatty acid composition. Prostaglandins Leukot. Essent. Fatty Acids. 59:1998;191-194
12. Lovejoy J.C., Smith S.R., Champagne C.M., et al. Effects of diets enriched in saturated (palmitic), monounsaturated (oleic), or trans (elaidic) fatty acids on insulin sensitivity and substrate oxidation in healthy adults. Diabetes Care. 25:2002;1283-1288
13. Tietz N.W. Clinical guide to laboratory tests. Third ed. 1995;268-273 Saunders, Philadelphia
14. Sapin R., Le Galudec V., Gasser F., Pinget M., Grucker D. Elecsys insulin assay: free insulin determination and the absence of cross-reactivity with Insulin-Lispro. Clin. Chem. 47:2001;602-605
15. Matthews D.R., Hosker J.P., Rudenski A., Naylor B.A., Treacher D.F., Turner R.C. Homeostasis model assessment: insulin resistance and β-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia. 28:1985;412-419
16. Lovejoy J.C., Champagne C.M., Smith S.R., et al. Relationship of dietary fat and serum cholesterol ester and phospholipid fatty acids to marker of insulin resistance in men and women with a range of glucose tolerance. Metabolism. 50:2001;86-92
17. Fernández-Real J.M., Broch M., Vendrell J., Ricart W. Insulin resistance, inflammation, and serum fatty acid composition. Diabetes Care. 26:2003;1362-1368
18. No authors listed. American Diabetes Association position statement: screening for type 2 diabetes. Diabetes Care. 26(Suppl. 1):2003;S21-S24
19. Christophe A.B., Matthijs F. New method for the determination of the fatty acid pattern of serum lipid classes. Clin. Chim. Acta. 16:1967;39-43
20. De Vriese S.R., Christophe A.B., Maes M. Lowered serum n-3 polyunsaturated fatty acid (PUFA) levels predict the occurrence of postpartum depression: further evidence that lowered n-PUFAs are related to major depression. Life Sci. 73:2000;3181-3187
21. Christophe A.B., Robberecht E., Franckx H., De-Baets F., Van-de-Pas M. Effect of administration of gamma-linolenic acid on the fatty acid composition of serum phospholipids and cholesteryl esters in patients with cystic fibrosis. Ann. Nutr. Metab. 38:1994;40-47
22. Pelikánová T., Kazdová L., Chvojková S., Base J. Serum phospholipid fatty acid composition and insulin action in type 2 diabetic patients. Metabolism. 50:2001;1472-1478
23. Brown J.E., Lindsay R.M., Riemersma R.A. Linoleic acid metabolism in the spontaneously diabetic rat: Δ6 desaturase activity vs. product/precursor ratios. Lipids. 35:2000;1319-1323
24. Schoonjans F., Zalata A., Depuydt C.E., Comhaire F.H. MedCalc: a new computer program for medical statistics. Comput. Methods Programs Biomed. 48:1995;257-262
25. Lands W.E. Long-term fat intake and biomarkers. Am. J. Clin. Nutr. 61(Suppl. 3):1995;721S-725S
26. Brenner R.R. Hormonal modulation of Δ6 and Δ5 desaturases: case of diabetes. Prostaglandins Leukot. Essent. Fatty Acids. 68:2003;151-162
27. Suneja S.K., Osei P., Cook L., Nagi M.N., Cinti D.L. Enzyme site-specific changes in hepatic microsomal fatty acid elongation in streptozotocin-induced diabetic rats. Biochim. Biophys. Acta. 1042:1990;81-85
28. Pagnan A., Corrocher R., Ambrosio G.B., et al. Effects of an olive-oil-rich diet on erythrocyte membrane lipid composition and cation transport systems. Clin. Sci. (Lond.). 76:1989;87-93
29. Corrocher R., Pagnan A., Ambrosio G.B., et al. Effects induced by olive-oil-rich diet on erythrocytes membrane lipid and sodium-potassium transports in postmenopausal hypertensive women. J. Endocrinol. Invest. 15:1992;369-376
30. Parillo M., Rivellese A.A., Ciardullo A.V., et al. A high- monounsaturated-fat/low-carbohydrate diet improves peripheral insulin sensitivity in non-insulin-dependent diabetic patients. Metabolism. 41:1992;1373-1378
31. Campbell L.V., Marmot P.E., Dyer J.A., Borkman M., Storlien L.H. The high-monounsaturated fat diet as a practical alternative for NIDDM. Diabetes Care. 17:1994;177-182
32. Jones C.N., Abbasi F., Carantoni M., Polonsky K.S., Reaven G.M. Roles of insulin resistance and obesity in regulation of plasma insulin concentrations. Am. J. Physiol. Endocrinol. Metab. 278:2000;E501-E508
33. Haber E.P., Ximenes H.M., Procopio J., Carvalho C.R., Curi R., Carpinelli A.R. Pleiotropic effects of fatty acids on pancreatic beta-cells. J. Cell. Physiol. 194:2003;1-12
34. Dixon G., Nolan J., McClenaghan N.H., Flatt P.R., Newsholme P. Arachidonic acid, palmitic acid and glucose are important for modulation of clonal pancreatic beta cell insulin secretion, growth and functional integrity. Clin. Sci. (Lond.). 106:2004;191-199
35. Pereira M.A., Jacobs D.R. Jr., Van Horn L., Slattery M.L., Kartashov A.I., Ludwig D.S. Dairy consumption, obesity, and the insulin resistance syndrome in young adults: the CARDIA study. JAMA. 287:2002;2081-2089
36. Gannon M.C., Nuttal F.Q., Krezowski P.A., Billington C.J., Parker S. The serum insulin and plasma glucose responses to milk and products in type 2 (non-insulin-dependent) diabetic patients. Diabetologia. 29:1986;784-791
37. Hu F.B., van Dam R.M., Liu S. Diet and risk of type II diabetes: the role of types of fat and carbohydrate. Diabetologia. 44:2001;805-817
38. Silha J.V., Krsek M., Skrha J.V., Sucharda P., Nyomba B.L., Murphy L.J. Plasma resistin, adiponectin and leptin levels in lean and obese subjects: correlations with insulin resistance. Eur. J. Endocrinol. 149:2003;331-335
39. Giannarelli R., Aragona M., Coppelli A., Del Prato S. Reducing insulin resistance with metformin: the evidence today. Diabetes Metab. 29:2003;6S28-6S35
40. Stolar M.W. Insulin resistance, diabetes and the adipocyte. Am. J. Health Syst. Pharm. 59(Suppl. 9):2002;S3-S8
41. Townsend R.R., Zhao H. Differential effect of insulin on saturated and unsaturated fatty acids. Metabolism. 51:2002;779-782